Pronounced interferon-alpha production from plasmacytoid dendritic cells in patients with Behçet's disease following CpG D ODN stimulation

Clinical and Experimental Rheumatology

Volumn 27, Issue 2 SUPPL.53, 2009, Pages

  Pay, Salih ^a   Pekel, Aysel ^a   Simsek, Ismail ^a   Musabak, Ugur ^a   Erdem, Hakan ^a   Dinc, Ayhan ^a   Kose, Osman ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Beh et's disease; CpG D ODN; Interferon alpha; Plasmacytoid dendritic cells

Indexed keywords

ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE;

ANKYLOSING SPONDYLITIS; ARTICLE; BEHCET DISEASE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

BEHCET SYNDROME; CASE-CONTROL STUDIES; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; LEUKOCYTES, MONONUCLEAR; SPONDYLITIS, ANKYLOSING;

EID: 70350165973     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. YAZICI H: Behçet's syndrome: an update. Curr Rheumatol Rep 2003; 5: 195-199
2. DIRESKENELI H: Autoimmunity vs. autoinflammation in Behçet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 2006; [Epub ahead of print].
3. SAYINALP N, OZCEBE OI, OZDEMIR O, HAZNEDAROGLU IC, DUNDAR S, KIRAZLI S: Cytokines in Behçet's disease. J Rheumatol 1996; 23: 321-322
4. BACON TH, OZBAKIR F, ELMS CA, DENMAN AM: Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol 1984; 57: 541-547
5. ERTENLI I, KIRAZ S, CALGÜNERI M et al.: Synovial fluid cytokine levels in Behçet's disease. Clin Exp Rheumatol 2001; 19 (Suppl. 24): S37-41.
6. MEGE JL, DILSEN N, SANGUEDOLCE V et al.: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993; 20: 1544-1549
7. MUSABAK U, PAY S, ERDEM H et al.: Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int 2006; 26: 545-550
8. FRASSANITO MA, DAMMACCO R, CAFFORIO P, DAMMACCO F: Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999; 42: 1967-1974
9. MELİKOGLU M, UYSAL S, KRUEGER JG et al.: Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. J Immunol 2006; 177: 6415-6421
10. BEN AHMED M, HOUMAN H, MİLED M, DELLAGİ K, LOUZİR H: Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 2004; 50: 2291-2295
11. KAPSENBERG ML: Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984-993
12. DRAKESMITH H, CHAIN B, BEVERLEY P: How can dendritic cells cause autoimmune disease? Immunol Today 2000; 21: 214-217
13. BLANCO P, PALUCKA KA, PASCUAL V, BANCHEREA J: Dendritic cell and cytokines in human inflammatory and autoimmun diseases. Cytokine Growth Factor Rev 2008; 19: 41-52.
14. COCCIA EM: IFN regulation and functions in myeloid dendritic cells. Cytokine Growth Factor Rev 2008; 19: 21-32. (Pubitemid 351200061)
15. ROGGE L, BARBERIS-MAINO L, BIFFI M et al.: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997; 185: 825-831 (Pubitemid 27119866)
16. NGUYEN KB, COUSENS LP, DOUGHTY LA, PIEN GC, DURBIN JE, BIRON CA: Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000; 1: 70-76
17. MCRAE BL, SEMNANI RT, HAYES MP, VAN SEVENTER GA: Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 1998; 160: 4298-304.
18. BARTHOLOME EJ, WILLEMS F, CRUSIAUX A, THIELEMANS K, SCHANDENE L, GOLDMAN M: Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis. Acta Neurol Belg 1999; 99: 44-52.
19. NAGAI T, DEVERGNE O, MUELLER TF, PERKINS DL, VAN SEVENTER JM, VAN SEVENTER GA: Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-betamediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol 2003; 171: 5233-5243
20. NAGAI T, DEVERGNE O, VAN SEVENTER GA, VAN SEVENTER JM: Interferon-β mediates opposing effects on interferon-γ dependent interleukin-12 p70 secretion by human monocyte-derived dendritic cells. Scand J Immunol 2006; 65: 107-117
21. KÖTTER I, KOCH S, VONTHEIN R et al.: Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 2005; 23 (Suppl. 38): S20-6.
22. PAY S, ŞİMŞEK I, ERDEM H et al.: Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization? Clin Exp Rheumatol 2007; 25 (Suppl. 45): S34-40.
23. VERTHEYI D, ISHIIKJ, GÜRSEL M, TAKESHITA F, KLINMAN DM: Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol 2001; 166: 2372-2377
24. GÜRSEL M, VERTHEYI D, GÜRSEL I, ISHII KJ, KLINMAN DM: Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukocyte Biol 2002; 71: 813-820
25. KWON HJ, LEE KW, YU SH, HAN JH, KIM DS: NF-Kappa B dependent regulation of tumor necrosis factor- alpha gene expression by CpG-oligodeoxynucleotides. Biochem Biophys Res Commun 2003; 311: 129-138
26. HEMMI H, KAISHO T, TAKEDA K, AKIRA S: The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003; 170: 3059-3064
27. GÜRSEL M, GÜRSEL I, MOSTOWSKI HS, KLINMAN DM: CXCL16 influences the nature and specificity of CpG-induced immune activation. J Immunol 2006; 177: 1575-1580
28. PLSKOVA J, GREINER K, MUCKERSIE E, DUNCAN L, FORRESTER JV: Interferon-alpha: A key factor in autoimmune disease? Invest Ophthalmol Vis Sci 2006; 47: 3946-3950.